Price volatility and impairment risk for securities held
First written in FY2022. 2 of 5 entries say "Materialised", first in FY2023. Latest entry: FY2026.
Pharma Foods International moved to the "Worse" side of this theme in 2023, 4 years after the typical company in this theme (2019).
The whole theme swung hardest in 2019: 69 of 144 companies on the "Worse" side.
53 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「For the fiscal year from 1 August 2025 to 31 July 2026, there were no applicable matters.」
Although the Company recorded an impairment loss of ¥118 million on investment securities in the previous fiscal year, no impairment loss was recognized on other securities during the fiscal year. - 2026-09-09MaterialisedOccurring Fact
「Accordingly, in the non-consolidated financial statements for the fiscal year ending July 2026, we expect to record a ¥422 million valuation loss on shares of an affiliated company as an extraordinary loss.」
The company expects to record a valuation loss on shares of an affiliated company because the underlying value of Onkyo Corporation shares declined, highlighting price fluctuation and impairment risk for investment securities. - FY2024WorsenedAnnual report
「During the current consolidated fiscal year, the company recognized an impairment loss of ¥123 million on other securities.」
Regarding the price fluctuation and impairment risks associated with securities held, the company actually recognized an impairment loss on investment securities of ¥123 million, up from ¥50 million in the previous fiscal year. - FY2023MaterialisedAnnual report
「Impairment loss on investment securities - 50」
Regarding the price fluctuation and impairment risks associated with securities held, the company actually recorded an impairment loss on investment securities of ¥50 million during the current consolidated fiscal year. - FY2022First statedAnnual report
「The Group may hold marketable securities for strategic reasons or to maintain business relationships, and is exposed to the risk of price fluctuations in those securities.」
The company has disclosed, for the first time as a separate item, the impairment risk associated with fluctuations in share and bond prices for strategic shareholdings and other securities.